Results 51 to 60 of about 2,298,895 (410)

Report on post-transplantation cancer in southeast Asia from the Thai kidney transplantation cohort

open access: yesScientific Reports
Post-transplantation cancer is a significant cause of mortality among kidney transplant recipients (KTR). The incidence of post-transplantation cancer varies based on geographic region and ethnicity.
Suthanit Laowalert   +10 more
doaj   +1 more source

Cost of lifetime immunosuppression coverage for kidney transplant recipients. [PDF]

open access: yes, 2008
On January 1, 2000, Medicare extended the coverage of immunosuppression medications from 3 years to life for elderly and disabled kidney transplant recipients.
Page, Timothy F, Woodward, Robert
core   +1 more source

Reduced CD40L expression on ex vivo activated CD4+T-lymphocytes from patients with excellent renal allograft function measured with a rapid whole blood flow cytometry procedure [PDF]

open access: yes, 2004
Background: The CD40-CD40L (CD154) costimulatory pathway plays a critical role in the pathogenesis of kidney allograft rejection. In renal transplant biopsies, CD4+ CD40L+ graft-infiltrating cells were detected during chronic rejection in contrast to ...
Friedrich, N.   +5 more
core   +1 more source

Organoids in pediatric cancer research

open access: yesFEBS Letters, EarlyView.
Organoid technology has revolutionized cancer research, yet its application in pediatric oncology remains limited. Recent advances have enabled the development of pediatric tumor organoids, offering new insights into disease biology, treatment response, and interactions with the tumor microenvironment.
Carla Ríos Arceo, Jarno Drost
wiley   +1 more source

Successful immunomodulation in kidney transplant recipients with cytokine release syndrome after coronavirus disease

open access: yesIJU Case Reports, 2022
Introduction Patients with coronavirus disease, especially solid organ transplant recipients, are more susceptible to developing cytokine release syndrome than those with other viral infections.
Daiji Takamoto   +9 more
doaj   +1 more source

Patient-Benefactors Support New Kidney Transplant Center [PDF]

open access: yes, 2017
December 14, 2017 was a landmark day at Jefferson: the ribbon cutting ceremony of the Nicoletti Kidney Transplant Center at Jefferson. This milestone venture – bringing together research, education and clinical care in one space – came to fruition thanks

core   +1 more source

Not All Antibodies Are Created Equal: Factors That Influence Antibody Mediated Rejection. [PDF]

open access: yes, 2017
Consistent with Dr. Paul Terasaki's "humoral theory of rejection" numerous studies have shown that HLA antibodies can cause acute and chronic antibody mediated rejection (AMR) and decreased graft survival. New evidence also supports a role for antibodies
Butler, Carrie L   +3 more
core   +4 more sources

Horseshoe kidney transplantation

open access: yesInterventional Medicine and Applied Science, 2015
Horseshoe kidney is a fusion anomaly found in approximately one in 400–600 people. Due to vascular and ureteral variations, transplantation with a horseshoe kidney presents a technical challenge. In our case, the isthmus connected the upper poles and contained parenchyma.
Nemes, BalĂĄzs   +7 more
openaire   +3 more sources

Pregnancy outcomes in women with kidney transplant: Metaanalysis and systematic review

open access: yesBMC Nephrology, 2019
BackgroundReproductive function in women with end stage renal disease generally improves after kidney transplant. However, pregnancy remains challenging due to the risk of adverse clinical outcomes.MethodsWe searched PubMed/MEDLINE, Elsevier EMBASE ...
Silvi Shah   +10 more
semanticscholar   +1 more source

COVID‐19 in an HIV‐positive kidney transplant recipient

open access: yesTransplant Infectious Disease, 2020
We report a case of a 50‐year‐old male with a history of HIV and kidney transplant who presented with SARS‐CoV‐2. We also present a review of COVID‐19 cases in kidney transplant recipients.
Rebecca N. Kumar   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy